100 related articles for article (PubMed ID: 36706377)
1. Participants' experience in using a point of Care Rapid Antigen Test (RAT) for SARS-CoV-2.
Ndateva I; Schwandt M; Saewyc E; Sin D; Tobias E; Wong S; Haase K; Ranger M
Ann Fam Med; 2022 Apr; 20(20 Suppl 1):. PubMed ID: 36706377
[TBL] [Abstract][Full Text] [Related]
2. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
5. Detection of SARS-CoV-2 infection in the general population by three prevailing rapid antigen tests: cross-sectional diagnostic accuracy study.
Venekamp RP; Veldhuijzen IK; Moons KGM; van den Bijllaardt W; Pas SD; Lodder EB; Molenkamp R; Igloi Z; Wijers C; Dos Santos CO; Debast SB; Bruins MJ; Polad K; Nagel-Imming CRS; Han WGH; van de Wijgert JHHM; van den Hof S; Schuit E
BMC Med; 2022 Feb; 20(1):97. PubMed ID: 35197052
[TBL] [Abstract][Full Text] [Related]
6. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
[TBL] [Abstract][Full Text] [Related]
7. Clinical Evaluation of BD Veritor SARS-CoV-2 and Flu A+B Assay for Point-Of-Care System.
Christensen K; Ren H; Chen S; Cooper CK; Young S
Microbiol Spectr; 2022 Apr; 10(2):e0180721. PubMed ID: 35412847
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients.
Koga P; Maluf M; Nunes F; Campos J; Gazarini L; Borghoff T; Libanori G; Martino M
Microbiol Spectr; 2022 Oct; 10(5):e0019022. PubMed ID: 36036635
[TBL] [Abstract][Full Text] [Related]
9. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission.
Rivett L; Sridhar S; Sparkes D; Routledge M; Jones NK; Forrest S; Young J; Pereira-Dias J; Hamilton WL; Ferris M; Torok ME; Meredith L; ; Curran MD; Fuller S; Chaudhry A; Shaw A; Samworth RJ; Bradley JR; Dougan G; Smith KG; Lehner PJ; Matheson NJ; Wright G; Goodfellow IG; Baker S; Weekes MP
Elife; 2020 May; 9():. PubMed ID: 32392129
[TBL] [Abstract][Full Text] [Related]
13. Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.
Kwan TH; Wong NS; Chan CP; Yeoh EK; Wong SY; Lee SS
JMIR Public Health Surveill; 2022 Nov; 8(11):e40175. PubMed ID: 36240027
[TBL] [Abstract][Full Text] [Related]
14. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
15. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
16. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of rapid antigen tests in asymptomatic and presymptomatic close contacts of individuals with confirmed SARS-CoV-2 infection: cross sectional study.
Schuit E; Veldhuijzen IK; Venekamp RP; van den Bijllaardt W; Pas SD; Lodder EB; Molenkamp R; GeurtsvanKessel CH; Velzing J; Huisman RC; Brouwer L; Boelsums TL; Sips GJ; Benschop KSM; Hooft L; van de Wijgert JHHM; van den Hof S; Moons KGM
BMJ; 2021 Jul; 374():n1676. PubMed ID: 34315770
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase-Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students.
Rauch JN; Valois E; Ponce-Rojas JC; Aralis Z; Lach RS; Zappa F; Audouard M; Solley SC; Vaidya C; Costello M; Smith H; Javanbakht A; Malear B; Polito L; Comer S; Arn K; Kosik KS; Acosta-Alvear D; Wilson MZ; Fitzgibbons L; Arias C
JAMA Netw Open; 2021 Feb; 4(2):e2037129. PubMed ID: 33570576
[TBL] [Abstract][Full Text] [Related]
19. Performance of the BD Veritor system SARS-CoV-2 antigen test among asymptomatic collegiate athletes: A diagnostic accuracy study.
Kepczynski CM; Genigeski JA; de Regnier DP; Jadhav ED; Sohn M; Klepser ME
Explor Res Clin Soc Pharm; 2021 Sep; 3():100047. PubMed ID: 34568868
[TBL] [Abstract][Full Text] [Related]
20. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
Kiang MV; Chin ET; Huynh BQ; Chapman LAC; Rodríguez-Barraquer I; Greenhouse B; Rutherford GW; Bibbins-Domingo K; Havlir D; Basu S; Lo NC
Lancet Infect Dis; 2021 Jul; 21(7):929-938. PubMed ID: 33765417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
